top of page


VI) Benovymed Global R&D and  AI Health Innovation Lab:


Benovymed Global R&D & AI Health Innovation is a Benovymed Thinktank for Concept to Commercialisation for our Benovymed 6 Business Verticals working Globally.
Our Research & Development
Our Addressable Diseases Areas in
Prevention  | Early Detection |  Dr Consultation | Diagnosis  |  Prognosis |  Treatment | End to End Complete Disease Management & Control 


1) COVID-19 Pandemic Management for Current & Future Emerging Infectious Diseases

(Communicable Diseases)


2) Chronic Diseases ( Non-Communicable Diseases)

Cancer | Diabetes | COPD | Heart Disease | Mental Health

Powered by:

Benovymed Global R&D and AI Health Innovation Lab

Science  |  Technology  |  Artificial Intelligence  |  Innovation

What is Benovymed Global R&D & AI Health Innovation Centre?


Benovymed Global R&D and AI Health Innovation Lab | Canter is the Benovymed ThinkTank from the day we conceive any New Innovative idea for our Benovymed 6 Business Verticals Global Business from Concept to its complete Commercialisation in India and Global Market.


Benovymed visionary & Passionate Founder & CEO of a World's Top 30 Most Impactful Global Business Leaders has set up and developed an "R&D and AI Health Innovation Lab"  after his strong experience of over 27 Years in healthcare in Digital Health, AI Health & Telemedicine Innovation Health Technology Products & Novel Solutions development in the areas of :


Prevention, Screening, Early Detection to Early warning & Early Prediction, Consultation, Prognosis, Diagnosis, Treatment, and Disease Management through Remote Patient Monitoring, Management & Patient engagement irrespective of any global location with 24x7x365 days Clinical Support & Management through our Highly Scalable Digital Health and AI Health Technology Platform. 

1) Top 5 Chronic Diseases

 Cancer  (Top20 Cancer Diseases including Breast Cancer, Cervical Cancer, Lung Cancer, Colorectal Cancer, and others)  | Diabetes | Heart Disease | Mental Health | COPD  and

2) Emerging Infectious Disease highly contagious deadly Corona Virus COVID-19 Pandemic Management,

Prevention, Early Warning & Early Prediction, Tracing, early detection, Dr. Consultation, Diagnosis, Prognosis, Treatment, Disease Management, Preparedness, and Readiness, COVID-19 Pandemic Health Disaster and Risk Management, Central Command, Capacity building for Stopping Transmission & Containment management.



  Our Global R&D and AI Health Innovation ThinkTank works on complete end to end from Concept to R&D to commericialisation Globally has set up and developed  a unique Central Command ThinkTank with deep mind driven R&D and Innovation which is uniquely placed in the core foundation of Benovymed Healthcare which can be trusted and bank upon by all stakeholders & Billions of People across the world and nowhere across the world such R&D and Innovation Centre till now exist in 360-degree areas of Healthcare with an objective of Ethical medical Practices, Quality Medical Practices, Highest Quality Standards, the highest level of Patient Safety, Highest Treatment efficacy, Highest Quality Health delivery with Highest Treatment Outcomes Per Procedures Per Treatment to bring change, Transformation in Healthcare in the areas of Doctor decision making ability, Empowering Doctors, medical Practices,Patient First, Patient care in Prevention, early detection, Dr Consultation, Disease Early warning, Prognosis,Diagnosis, Treatment & complete Disease Management using Science & Technology in Digital Health, AI Health & Telemedicine and in the areas of Market Research,Product fit Market Fit Clinical Validations and Clinical Developments, Healthcare Business Commercilaisation & Management, Product dvelopement & Innovation Stratgey, Business Risk Management, which is called as 

"Benovymed Global R& D and AI Health Innovation Lab"


After a series of massive serial Fundraising, Benovymed will be converting its Highly Scalable R&D & AI Health Innovation Lab into a world-class R&D and AI Health Innovation Centre called as

" Benovymed Global R&D and AI Health Innovation Centre "      

Powered by:

Benovymed R&D and AI Health Innovation Lab

Science  |  Technology  |  Artificial Intelligence  |  Innovation

As per our 5-Year Business Plan this World’s Class & State of an art World's First of its Kind World Class Global R&D and Innovation Centre with a massive Investment through a series of Venture Fundraising of over 30 Billion USD.

Our Benovymed Global R&D and AI Health Innovation Think Tank will be our Major Growth Driver and make Benovymed Healthcare Global Organisation the fastest growing into more than 300 Billion Dollars by Market Valuation the world's 1st AI Health Global Organisation from India.

Benovymed is working in a Trillion Dollar AI Health Global Market which is the fastest growing Market at CAGR 61.3% annually 2020-28 with an underserved market with no supply and exponentially high growing demand globally and within a Few Trillion Dollars of underserved Chronic Diseases (Cancer | Diabetes | Heart Disease | Mental Health | COPD ) including Top 20 Cancer Diseases demand growing at more than 51.4 % Annually  & underserved and unmet exponential demand of COVID-19 Pandemic Management ( COVID-19 Transmission Tracing, early warning, Testing & Treating readiness, preparedness, COVID-19 Disease Management Capacity Building).

Our Benovymed Global R&D and AI Health Innovation Centre will be the Benovymed Exponential Sustainable Growth Drivers & Powerhouse of Benovymed which is a Game-Changer R&D and Innovation Think-tank in 360 Degree areas from Concept to Commercialisation of our over 2000 game changer Digital Technology Products Lines & Novel Solutions to solve 1000s of complex problems in Healthcare as per every country local Problems in over 180 countries Healthcare Problems in Public Health, Chronic Diseases ( Non-Communicable Diseases) & Communicable Disease ( Emerging Highly contagious deadly Infectious Diseases such as COVID-19, EBOLA, H1N1, Swine Flu, Dengue, Chikungunya,  & Japanese Encephalitis Virus, Leptospira & Rickettsia).

We are expanding and working in partnership collaboration with all Key Authorities & all stakeholders ( Hospitals, Doctors, Pharma Co, Insurance Co, MNC / Corporates, Thinktank and Ministry of Health (MOH) of every Countries government, Top-rated Medical Research Universities & Top Rated Technology Research Institutes in more than 180 Countries globally including India, Corporates, NGO, Not for Profit Global Organisation, UN & WHO.

We are coming up soon in Delhi NCR, India our new Corporate HQ, Global HQ, Global Technology Development Centre & Global R&D, and AI Health Innovation Centre.​​​​

Benovymed is developing the world's first-of-its-kind R&D and AI Health Innovation Center which will be the world's No:1, world-class and the state of art R&D & AI Health Innovation Global Center coming up in our Global HQ, Global Technology Development Center, Global R&D & AI Health Innovation Center in Delhi, India. Powered by: Benovymed R&D and AI Health Innovation Lab.   

We are setting up a state of the Art "Centre of Excellence in Healthcare R&D and AI Health Innovation" which will be the World's 1st  of its Kind Global AI Health Innovation for solving Complex Problems existing and in emerging Infectious Disease areas in our Healthcare System from the complete inside out to benefits all stakeholders with a Patient-Centric Solutions Globally.


As per our next 5-year business plan, we will be having within next 5 Year timeline Total Team size of more than 20,000 growth drivers and major contributors including the world's best team of more than 2000 AI Health Data Scientists, 1000 Medical Researchers, 2000 Medical Specialist, 5000 IT Engineering Professionals, 8,000 Global Business Development, and 4000 Global Operation Team from across the world's Best Technology & Research Institutes  & Medical Research University Hospitals at our India Global HQ to work on Thousands of complex problems in Healthcare to bring change in Healthcare to Impact the Life of Billions of People Globally to support our country "Make in India" Programme exporting Impact Innovation Novel Technologies Solutions with solving every country local problems, local challenges, and global problems globally.

As per our 5 years Business Plans, Benovymed Healthcare will be the World's First most impactful Deep Digital Health AI Health & Telemedicine Innovation Global Healthcare Organisation in Prevention, Early Detection, Diagnosis, and Complete Disease Management & Control of COVID-19 ( Top Deadly Communicable Disease ) Pandemic Management & Top 5 Chronic Disease ( Cancer | Heart Disease | Diabetes | COPD | Mental Health ) Management ( Non-Communicable Disease ) a highly sustainable fastest-growing with double-digit Profit by Revenue global organization with over Ten Billion US Dollars by valuation in the next 5 years time.

Our 5-Year Business Plan for Product Development & Innovation

As per our 5 Year Business Plan, In current Phase1, we have built and developed a Highly Scalable and Highly sustainable growth world's 1st most comprehensive multidisciplinary AI Health Platform which will be having one after the other in phase by phase, year by year fund by fund down the line in next 5 year starting with currently first developed 21, then another 100, 200 and then add on to have in total more than 2000 Disruptive Innovative Technology Products, Solutions & Services backed by Next-generation Science & Technology in Disease Prevention, Early Detection & Disease management, Medical Practice, Medical Innovation, Digital Health, AI Health, Telemedicine Innovation, IoT's, Blockchain Technology with the highest safety, Highest efficacy, Treatment Outcomes, security for patients and High Profitability to all stakeholders globally. 

We have already converted our 21 POC into Products and developed into working 21 Products in Phase 1,  out of our disruptive, Innovative Products & Solutions 400 POC were conceived & developed by our Founder & CEO. 

The remaining 379 POC will be converted into 379 Products & Solutions in our phases 2 & 3  and thereby growing to have a total of more than 2000 disruptive, Innovative Technology Products and Novel Solutions to be placed on our world's 1st most comprehensive multidisciplinary AI Health Platform Phase by phase within the next 5 Years with year by year funding as per our next 5 years business plan.

Our Founder & CEO have developed after his excellent healthcare experience on the ground in his long continuing R&D experience while he worked in building many Global HealthTech Startup from concept to commercialization and launched over 90 Innovative Digital Health Technologies, AI Health, Medical Technologies Products and solutions which were applied and used on several hundred thousands of Patients treatments and procedures inside thousands of Hospitals, Clinics and in Public health system in last 30 years in the experience of our founder & CEO. 

Thereafter, our Founder & CEO in his long ongoing R&D experience has developed more than 400 new POC's Products and solutions which we will be rolling out in phase by phase in next 3 years globally in high sustainable Growth market of several Trillions dollars growing annually at CAGR 54.3 % , applying next Generation Science & Technology, Digital Health, Telemedicine &  AI Health from the pain point of Patients, doctors, hospitals, government and all other healthcare stakeholders and from the gap analysis in more than 500 complex problems in various Health super speciality for Prevention of Health, Early detection, Diagnosis, Disease Management & Disease control and COVID-19 Pandemic Management and in the Treatment procedure in the Healthcare system and we have come out with their respective our Innovative Novel Solutions for those complex problems in the health system and developing them in a highly sustainable growth model of highly scalable Digital Health Technology Deep AI Health Telemedicine driven business model in phase by phase in next 3 years timeline.


Benovymed Global R&D and AI Health Innovation Lab.png
Our Product

Product | Solutions | Services

bottom of page